Pages that link to "Q45730189"
Jump to navigation
Jump to search
The following pages link to Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients (Q45730189):
Displaying 50 items.
- Viral hepatitis and hepatocellular carcinoma (Q21245597) (← links)
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C (Q24200189) (← links)
- Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C (Q24200197) (← links)
- Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus (Q24202464) (← links)
- Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for chronic hepatitis C (Q24240315) (← links)
- Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C (Q24241360) (← links)
- Pegylated interferon for acute hepatitis C (Q24243723) (← links)
- Pegylated interferon alpha 2a versus pegylated interferon alpha 2b for acute and chronic hepatitis C (Q24245279) (← links)
- Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C (Q24246836) (← links)
- Natural History and Clinical Consequences of Hepatitis B Virus Infection (Q24810151) (← links)
- Management of HBV and HBV/HDV-Associated Liver Cirrhosis (Q26740323) (← links)
- Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview (Q26745650) (← links)
- KASL clinical practice guidelines: management of chronic hepatitis B (Q26752475) (← links)
- Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis (Q26775804) (← links)
- Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis (Q26783356) (← links)
- Does antiviral therapy reduce complications of cirrhosis? (Q26851410) (← links)
- Management of patients with hepatitis B in special populations (Q27016136) (← links)
- Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis (Q27489394) (← links)
- Seroprevalence of HBV and HCV in primary hepatocellular carcinoma patients in Zimbabwe (Q27490198) (← links)
- The new era of hepatitis C virus therapy (Q28086947) (← links)
- Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease (Q28088566) (← links)
- A novel estimation of the relative economic value in terms of different chronic hepatitis B treatment options (Q28704122) (← links)
- The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma (Q30250096) (← links)
- Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis (Q30251618) (← links)
- Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study (Q33621731) (← links)
- Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations (Q33866448) (← links)
- Clinical outcomes of compensated and decompensated cirrhosis: A long term study (Q33948229) (← links)
- Antiviral treatment of chronic hepatitis B virus (HBV) infections (Q34223779) (← links)
- Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. (Q34264888) (← links)
- The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology (Q34338519) (← links)
- AASLD guidelines for treatment of chronic hepatitis B. (Q34501660) (← links)
- Natural history of hepatitis-related hepatocellular carcinoma. (Q34589546) (← links)
- Decreasing disparity in liver transplantation among white and Asian patients with hepatocellular carcinoma : California, 1998-2005. (Q34789209) (← links)
- The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States (Q34990604) (← links)
- Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade (Q35065472) (← links)
- Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity (Q35105877) (← links)
- Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial (Q35322521) (← links)
- The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection (Q35590977) (← links)
- Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. (Q35596873) (← links)
- Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial (Q35621231) (← links)
- Natural history of hepatitis B. (Q35621647) (← links)
- Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study (Q35747990) (← links)
- Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study (Q35785156) (← links)
- Establishing the link between hepatitis B virus infection and colorectal adenoma (Q36062572) (← links)
- Cost-effectiveness and population outcomes of general population screening for hepatitis C. (Q36115516) (← links)
- KASL Clinical Practice Guidelines: Management of chronic hepatitis B. (Q36153966) (← links)
- The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country (Q36189795) (← links)
- Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. (Q36382269) (← links)
- Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation (Q36444618) (← links)
- Lamivudine treatment in patients with chronic hepatitis B and cirrhosis (Q36573919) (← links)